Oxford Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$597K Buy
2025
Q1
$152K Buy
2024
Q4
$99K Buy
2018
Q4
Sell
2018
Q3
$747K Sell
2018
Q2
$1.17M Sell
2018
Q1
$1.58M Buy
2017
Q4
$1.21M Buy
2017
Q3
$61K Sell
2017
Q2
$660K Buy
2016
Q1
Sell
2015
Q4
$110K Sell
2015
Q3
$2.66M Buy
2014
Q4
Sell
2014
Q3
$2.07M Sell
2014
Q2
$3.73M Buy